Forum

He timeFig. 2 Flowchart depicting number of patients that were included in analysis after exclusion criteria. The total included encounters were divided as AKI or without AKIKate et al. BMC Medical Informatics and Decision Making (2016) 16:Page 5 ofTable 1 Distribution of various variables in AKI and non-AKI encounters. For numeric variables, mean and standard deviation are shown; categorical variables are shown with the number of occurrences and percentagesVariable Demographics Age BMI Race = White Race = Black Race = Other Sex = Female Sex = Male Tobacco Use = Never Tobacco Use = Quit Tobacco Use = Yes Alcohol Use Family History Laboratory Values BUN AST Troponin Blood Bilirubin Platelet Count Heart Rate Temperature BP systolic BP diastolic Medications ACE Inhibitors ARB Naloxegol oxalate NSAIDS Lipid Lowering Drugs Diuretics ACE Inhibitors or NSAIDS or Diuretics ARB or ACE Inhibitors or NSAIDS or Diuretics K Sparing Aminoglycoside Antibiotics Radiocontrast Dyes Cisplatin Acyclovir Comorbidities Prior AKI Diabetes Hyperlipidemia Hypercalcemia Thrombocytopenia Hypertension 378 (16.74 ) 223 (9.88 ) 392 (17.36 ) 32 (1.417 ) 103 (4.56 ) 453 (20.06 ) 1470 (6.32 ) 1410 (6.06 ) 3127 (13.44 ) 222 (0.95 ) 567 (2.43 ) 3518 (15.12 ) <0.0001 <0.0001 <0.0001 <0.05 <0.0001 <0.0001 1219 (54.0 ) 422 (18.7 ) 821 (36.36 ) 1539 (68.16 ) 1750 (77.50 ) 2052 (90.88 ) 2076 (91.94 ) 284 (12.58 ) 241 (10.67 ) 1536 (68.02 ) 31 (1.37 ) 119 (5.27 ) 10869 (46.7 ) 3851 (16.6 ) 8619 (37.05 ) 15233 (65.48 ) 13654 (58.69 ) 19111 (82.15 ) 19580 (84.17 ) 1786 (7.68 ) 1986 (8.54 ) 14229 (61.17 ) 267 (1.15 ) 1170 (5.03 ) <0.0001 <0.02 0.5312 <0.02 <0.0001 <0.0001 <0.0001 <0.0001 <0.001 <0.0001 0.3963 0.6539 25.81 ?14.27 35.49 ?29.02 3.98 ?3.13 0.77 ?0.56 214.33 ?92.98 84.2 ?19.0 98.2 ?1.2 140 ?32 72 ?16 17.45 ?8.63 27.79 ?18.7 1.31 ?1.12 0.60 ?0.37 215.11 ?85.71 81.3 ?18.7 98.1 ?1.6 138 ?28 71 ?14 <0.0001 <0.0001 <0.0001 <0.0001 0.686 <0.0001 0.08 <0.01 <0.04 75.2 ?9.5 29.7 ?8.2 1974 (87.4 ) 198 (8.8 ) 27 (1.2 ) 1101 (48.8 ) 1154 (51.1 ) 767 (34.0 ) 1281 (56.7 ) 193 (8.5 ) 705 (31.2 ) 37 (1.64 ) 75.3 ?9.6 28.4 ?7.3 20940 (90.0 ) 1571 (6.8 ) 240 (1.0 ) 12426 (53.4 ) 10791 (46.4 ) 8601 (37.0 ) 12118 (52.1 ) 2360 (10.1 ) 8037 (34.6 ) 442 (1.90 ) 0.799 <0.0001 <0.0001 <0.0004 0.5331 <0.0001 <0.0001 <0.005 <0.0001 <0.02 <0.002 0.4280 AKI (2258) Non-AKI (23263) P-valueKate et al. BMC Medical Informatics and Decision Making (2016) 16:Page 6 ofTable 1 PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/8309954 Distribution of various variables in AKI and non-AKI encounters. For numeric variables, mean and standard deviation are shown; categorical variables are shown with the number of occurrences and percentages (Continued)Heart Failure Coronary Artery Disease Disorders of Lipoid Metabolism Pancreatitis Rhabdomyolysis Congestive Heart Failure Sepsis Respiratory FailureThe p-values less than 0.05 are shown in bold272 (12.05 ) 250 (11.07 ) 134 (5.93 ) 51 (2.26 ) 19 PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/1333685 (0.84 ) 272 (12.04 ) 230 (10.19 ) 363 (16.08 )1442 (6.20 ) 1670 (7.18 ) 1413 (6.07 ) 342 (1.47 ) 164 (0.70 ) 1442 (6.20 ) 1324 (5.69 ) 1271 (5.46 )<0.0001 <0.0001 0.8265 <0.005 0.5464 <0.0001 <0.0001 <0.excluded with remaining 25,251 encounters used for analysis. The total included encounters were divided as AKI (n = 2,258) or without AKI (n = 23,263). Patient characteristics separated by AKI and non-AKI status are depicted in Table 1. All demographics except for age, those belonging to a race other than Black or White and fa.